A detailed history of Nomura Holdings Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 214,128 shares of BBIO stock, worth $7.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
214,128
Previous 225,237 4.93%
Holding current value
$7.89 Million
Previous $5.73 Million 2.46%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$22.35 - $29.5 $248,286 - $327,715
-11,109 Reduced 4.93%
214,128 $5.88 Million
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $71,658 - $93,806
-2,997 Reduced 1.31%
225,237 $5.73 Million
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $3.53 Million - $4.76 Million
-153,411 Reduced 40.2%
228,234 $5.78 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $10.4 Million - $15.4 Million
381,645 New
381,645 $11.8 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $552,123 - $1.01 Million
22,986 Added 9.78%
257,995 $10.4 Million
Q3 2023

Nov 14, 2023

SELL
$16.89 - $35.01 $1.53 Million - $3.18 Million
-90,744 Reduced 27.86%
235,009 $6.2 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $1.07 Million - $1.45 Million
80,658 Added 32.91%
325,753 $5.6 Million
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $928,930 - $2.4 Million
129,558 Added 112.14%
245,095 $4.06 Million
Q4 2022

Feb 14, 2023

SELL
$6.74 - $11.52 $319,091 - $545,391
-47,343 Reduced 29.07%
115,537 $878,000
Q3 2022

Nov 15, 2022

BUY
$7.94 - $12.36 $126,206 - $196,462
15,895 Added 10.81%
162,880 $1.62 Million
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $45,983 - $107,147
-8,826 Reduced 5.66%
146,985 $1.46 Million
Q1 2022

May 18, 2022

SELL
$7.34 - $17.16 $521,477 - $1.22 Million
-71,046 Reduced 31.32%
155,811 $1.69 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $21,371 - $100,303
1,878 Added 0.83%
226,857 $3.79 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $71,054 - $97,387
1,516 Added 0.68%
224,979 $10.7 Million
Q2 2021

Aug 16, 2021

BUY
$46.47 - $63.93 $11,571 - $15,918
249 Added 0.11%
223,463 $13.6 Million
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $12.1 Million - $15.8 Million
218,884 Added 5055.06%
223,214 $13.7 Million
Q4 2020

Feb 16, 2021

SELL
$38.38 - $71.11 $359,543 - $666,158
-9,368 Reduced 68.39%
4,330 $308,000
Q3 2020

Nov 12, 2020

BUY
$27.2 - $42.19 $372,585 - $577,918
13,698 New
13,698 $514,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $5.46B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.